To present a multi-delay pseudo-continuous ASL (pCASL) protocol that offers simultaneous measurements of cerebral blood flow (CBF) and arterial transit time (ATT), and to study correlations between multi-delay pCASL and CT perfusion in moyamoya disease. A 4 post-labeling delay (PLD) pCASL protocol was applied on 17 patients with moyamoya disease who also underwent CT perfusion imaging. ATT was estimated using the multi-delay protocol and included in the calculation of CBF. ASL and CT perfusion images were rated for lesion severity/conspicuity. Pearson correlation coefficients were calculated across voxels between the two modalities in grey and white matter of each subject respectively and between normalized mean values of ASL and CT perfusion measures in major vascular territories. Significant associations between ASL and CT perfusion were detected using subjective ratings, voxel-wise analysis in grey and white matter and region of interest (ROI)-based analysis of normalized mean perfusion. The correlation between ASL CBF and CT perfusion was improved using the multi-delay pCASL protocol compared to CBF acquired at a single PLD of 2 s (P < 0.05). There is a correlation between perfusion data from ASL and CT perfusion imaging in patients with moyamoya disease. Multi-delay ASL can improve CBF quantification, which could be a prognostic imaging biomarker in patients with moyamoya disease. aEuro cent Simultaneous measurements of CBF and ATT can be achieved using multi-delay pCASL. aEuro cent Multi-delay ASL was compared with CT perfusion in patients with moyamoya disease. aEuro cent Statistical analyses showed significant associations between multi-delay ASL and CT perfusion. aEuro cent Multi-delay ASL can improve CBF quantification in moyamoya disease.
基金:
Ministry of Science and Technology (MOST) of ChinaMinistry of Science and Technology, China [2012CB825500, 2010IM030800]; National Nature Science Foundation of China (NSFC)National Natural Science Foundation of China [30830101, 91132302, 90820307]; CAS Knowledge Innovation ProjectKnowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-259]; CAS Strategic Priority Research Program [XDB02010001, XDB02050001]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH080892, R01-NS081077, R01-EB014922]